The lipoprotein profile of women with hyperprolactinaemic amenorrhoea

Human Reproduction

Volumn 14, Issue 2, 1999, Pages 285-287

  Fahy, U ^a,c   Hopton, M I ^b   Hartog, M ^b   Bolton, C H ^b   Hull, M G R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Hyperprolactinaemia; Lipoprotein profile

Indexed keywords

BROMOCRIPTINE; CHOLESTEROL; DOPAMINE RECEPTOR STIMULATING AGENT; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; PROLACTIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AMENORRHEA; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FUNCTION; PROLACTIN BLOOD LEVEL; SMOKING; STATISTICAL ANALYSIS;

EID: 0033051673     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.2.285     Document Type: Article

References (26)

1. Bevan, J.S., Sussman, J., Roberts, A. et al. (1989) Development of an invasive microprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report. Br. J. Obstet. Gynaecol., 96, 1440-1444.
2. Bush, T.L., Barrett-Connor, E., Cowan, L.D. et al. (1987) Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation, 75, 1102-1109.
3. Cann, C.E., Martin, M.C., Genant, H.K. and Jaffe, R.B. (1984) Decreased spinal mineral content in amenorrheic women. JAMA, 251, 626-629.
4. Fahy, U.M., Foster, A., Torode, H.W. et al. (1992) The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrhea. Gynecol. Endocrinol., 6, 183-188.
5. Farish, E., Fletcher, C.D., Hart, D.M. and Smith, M.L. (1990) Effects of bilateral oophorectomy on lipoprotein metabolism. Br. J. Obstet. Gynaecol., 97, 78-82.
6. Fehily, A.M., Yarnell, J.W.G., Bolton, C.H. and Butland, B.K. (1988) Dietary determinants of plasma lipids and lipoproteins: the Caerphilly study. Eur. J. Clin. Nutr., 42, 405-413.
7. Friis, T. and Pedersen, L.R. (1987) Serum lipids in hyper-and hypothyroidism before and after treatment. Clin. Chim. Acta, 162, 155-163.
8. Gooren, L.J.G., Assies, J., Asscheman, H. et al. (1988) Estrogen induced prolactinoma in a man. J. Clin. Endocrinol. Metab., 66, 444-446.
9. Gordon, T., Kannel, W.B., Hjortland, M.C., McNamara, P.M. (1978) Menopause and coronary heart disease: the Framingham Study. Ann. Int. Med., 89, 157-161.
10. Henderson, B.E., Paganini-Hill, A. and Ross, R.K. (1991) Decreased mortality in users of estrogen replacement therapy. Arch. Int. Med., 151, 75-78.
11. Hesmati, H.M., Turpin, G. and de Gennes, J.L. (1987) Chronic hyperprolactinemia and plasma lipids in women. Klin. Wochenschr., 65, 516-519.
12. Hunt, K., Vessey, M. and McPherson, K. (1990) Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br. J. Obstet. Gynaecol., 97, 1080-1086.
13. Klibanski, A., Neer, R., Beitins, I.Z. et al. (1980) Decreased bone density in hyperprolactinaemic women. N. Engl. J. Med., 303, 1511-1514.
14. Klibanski, A., Biller, B.M.K., Rosenthal, D. et al. (1988) Effects of prolactin and oestrogen deficiency in amenorrheic bone loss. J. Clin. Endocrinol. Metab., 67, 124-130.
15. Kung, A.W.C., Pang, R.W.C. and Janus, E.D. (1995) Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin. Endocrinol., 43, 445-449.
16. Matthews, K.A., Meilahn, E., Kuller, L.H. et al. (1989) Menopause and risk factors for coronary heart disease. N. Engl. J. Med., 321, 641-646.
17. Muls, E., Rosseneu, M., Blaton, V. et al. (1984) Serum lipids and apolipoproteins A-I, A-II, and B in primary hypothyroidism before and during treatment. Eur J. Clin. Invest., 14, 12-15.
18. Olive, K.E. and Hennessey, J.V. (1988) Marked hyperprolactinemia in subclinical hypothyroidism. Arch. Int. Med., 148, 2278-2279.
19. Oliver, M.F. and Boyd, G.S. (1959) Effect of bilateral ovariectomy on coronary artery disease and serum-lipid levels. Lancet, ii, 690-694.
20. Pelkonen, R., Nikkila, E.A. and Grahne, B. (1982) Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. Clin. Endocrinol., 16, 383-390.
21. Schlechte, J.A., Sherman, B. and Martin, R. (1983) Bone density in amenorrheic women with and without hyperprolactinaemia. J. Clin. Endocrinol. Metab., 56, 1120-1123.
22. Semple, C.G., Beastall, G.H., Teasdale, G. and Thomson, J.A. (1983) Hypothyroidism presenting with hyperprolactinaemia. Br. Med. J., 286, 1200-1201.
23. Stampfer, M.J., Colditz, G.A., Willett, W.C. et al. (1991) Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses' Health Study. N. Engl. J. Med., 325, 756-762.
24. Stevenson, J.C., Crook, D. and Godsland, I.F. (1993) Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis, 98, 83-90.
25. Sznajderman, M. and Oliver, M.F. (1963) Spontaneous premature menopause, ischaemic heart-disease, and serum lipids. Lancet, i, 962-965.
26. Walsh, B.W., Schiff, I., Rosner, B. et al. (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med., 325, 1196-1204.